GlassScriptPhysician profile
Joseph I Lee
NPI 1922026582
$1,312.89
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $180 · 2024: $61.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $210.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $188.13 | 2019-2020 | |
| Pfizer INC. | $165.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.77 | 2019 | |
| Merck Sharp & Dohme LLC | $93.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $79.48 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $78.89 | 2019-2020 | |
| Biotissue Holdings INC. | $61.06 | 2024 | |
| Novartis Pharmaceuticals Corporation | $59.35 | 2019-2020 | |
| Astellas Pharma US INC | $44.52 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $44.43 | 2019 | |
| Amarin Pharma, INC. | $39.17 | 2019-2020 | |
| Horizon Therapeutics Plc | $33.54 | 2019 | |
| Glaxosmithkline, LLC. | $31.93 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $18.53 | 2019 | |
| Boston Scientific Corporation | $16.66 | 2019 | |
| Lilly USA, LLC | $14.41 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.